DESTETRAHYDROFURANYL-5-METHYLTETRAHYDROFURAN-2-YL TERAZOSIN
UNII N0C166ET1K

Substance Identification & Data

This profile provides standardized clinical and technical data for Destetrahydrofuranyl-5-methyltetrahydrofuran-2-yl Terazosin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N0C166ET1K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1177261-85-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N0C166ET1K

CAS Registry Number

1177261-85-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DESTETRAHYDROFURANYL-5-METHYLTETRAHYDROFURAN-2-YL TERAZOSIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H27N5O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HKXGJHSYGLAWLN-SFVWDYPZSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

72941989

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1(CCN(C(=O)C2O[C@@H](C)CC2)CC1)c3nc(N)c4cc(OC)c(OC)cc4n3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Destetrahydrofuranyl-5-methyltetrahydrofuran-2-yl Terazosin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.